GPVI-mediated and von Willebrand Factor (vWF)-mediated platelet adhesion and activation play an important role in thrombus formation and subsequent development of stroke and could be a target for pharmacological inhibition of pathological thrombus formation [3]. This evidence concerns the gene VWF and stroke disorder.